Welcome

to the joint symposium of Scandinavian Society of Neuro-oncology (SNOG) and Finnish Brain Tumor Research Association (FiBTRA), which will be held in Tampere, Finland May 19-21, 2022. The symposium is targeted to clinical experts, clinical researchers and basic scientists who work with brain tumors.

Speakers

Keynote speakers

Keynote speakers

Professor Frank Furnari, University of California San Diego (UCSD) and Ludwig Institute for Cancer Research, San Diego, USA

Professor Frank Furnari will present how the genome engineering of human pluripotent cells allows the generation of brain cancer avatars for research and therapeutic intervention. His research group studies the fundamental pathways that drive initiation and progression of glioblastoma and other brain tumors and aims to discover novel therapeutically actionable targets for these malignancies by taking intra-tumoral heterogeneity also into account.

Doctor Itay Tirosh, Weizmann Institute of Science, Rehovot, Israel

Doctor Itay Tirosh will talk about the interactions between cancer and immune cells within the glioblastoma microenvironment. His research group has together with his collaborators revealed multidirectional crosstalk between glioblastoma and immune cells which alters the phenotypes on both sides. They are leveraging experimentation, especially single cell technologies, computational approaches, and clinical collaborations to characterize important tumor subpopulations such as cancer stem cells, drug resistant cells, invasive cells and immune cells in the tumor tissue.

Professor Roel Verhaak, Jackson Laboratory, Farmington, CT, USAand Amsterdam University Medical Center, Amsterdam, Netherlands

Professor Roel Verhaak will talk about longitudinal evolution of glioma in adult patients. He has been one of the key PIs in The Cancer Genome Atlas (TCGA) project, which has been instrumental in characterizing diffuse gliomas and other malignancies, revealed their heterogeneity and different tumor subtypes. This work has also been relevant for the renewal of diffuse glioma classification based on the genetic markers. He is leading a computational cancer biology group with a research focus on the analysis of cancer genomics data to understand the progression of diffuse glioma.

Professor Frank Winkler, University Hospital Heidelberg and German Cancer Research Center, Heidelberg, Germany

Professor Frank Winkler will talk about malignant cell networks in the brain and ways to target them therapeutically. His research group have made seminal discoveries on the role of communicating brain tumor cell networks, hijacking of neurodevelopmental pathways for tumor progression, and the key steps of brain metastasis formation in a manner that helps to partly explain therapy resistance and provide new avenues for treatment. They are utilizing advanced imaging approaches in their work to study tissue and cell dynamics over several months from a variety of perspectives.


Other speakers will cover a variety of topics, ranging from brain tumor epidemiology to improved neurosurgery applications, tumor biology, potential biomarkers, and up-to-date treatment modalities.

Invited speakers

Professor Anssi Auvinen, Tampere University, Tampere, Finland
Orcid
Tuni Research Portal

Doctor Jiri Bartek, Karolinska University Hospital, Stockholm, Sweden 
Research page

Professor Martin van den Bent, ErasmusMC Cancer Institute, Rotterdam, the Netherlands
Orcid
Hersen Tumor Center

Doctor Malin Blomstrand, Sahlgrenska University Hospital, Gothenburg, Sweden

Doctor Leena Kankaanranta, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Doctor Sara Kinhult, Lund University, Lund, Sweden

Adjunct professor Päivi Koroknay-Pal, Helsinki University Hospital, Helsinki, Finland

Associate Professor Miikka Korja, University of Helsinki and Helsinki University Hospital, Helsinki, Finland (tentatively accepted)   

Adjunct professor Nea Malila, Director of the Finnish Cancer Registry, Cancer Society of Finland, Finland 
Finnish Cancer Registry

Adjunct professor Simone Niclou, Luxembourg Institute of Health, Luxembourg and University of Bergen, Bergen, Norway
Simone Niclou Research Group
Orcid

Professor Hans Skovgaard Poulsen, The DCCC Brain Tumor Center, Copenhagen University Hospital, Copenhagen, Denmark

Professor Ole Solheim, St. Olavs Hospital, Trondheim, Norway
GoogleScholar

Doctor Manuel Valiente, CNIO, Madrid, Spain
Brain Metastasis Group
Manuel Valiente Laboratory

Doctor Joachim Weischenfeldt, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
Orcid
Research group



Please note, that the program might still change due to exceptional circumstances. Latest version and updates are presented here on the symposium web pages.

General information

Welcome to the joint symposium of Scandinavian Society of Neuro-oncology (SNOG) and Finnish Brain Tumor Research Association (FiBTRA), which will be held in Tampere, Finland May 19-21, 2022. The symposium is targeted to clinical experts, clinical researchers and basic scientists who work with brain tumors.

The meeting will take place in the pleasant venue of Paja Conference Centre, one of the most atmospheric surroundings at Tampere city center. There are direct flights to Tampere and it is around 2 hours from Helsinki airport by train.

We warmly look forward for your participation to this interesting and atmospheric symposium. We can accept maximum 200 participants to our symposium.

Programme

Preliminary programme (updated 19.4.2021)

SNOG-FiBTRA Symposium: Multidisciplinary Neuro-Oncology       
Paja Congress Center, Tampere, 19-21 May 2022 

Thursday 19 May 2022

Session 1 Brain tumors among us today

Session 2 Heterogeneity and evolution of brain tumors

Session 3 Up-to-date treatment modalities

Friday 20 May 2022

Session 4 Biomarkers in brain tumors

Session 5 Neurosurgery

Session 6 Signaling in brain tumors

Session 7 Why targeted therapies fail in clinical trials?

Saturday 21 May 2021

Session 8 Brain tumor immunology and microenvironment

Session 9 Patient stratification and treatment

Session 10 Brain metastases

The meeting will start on 19. May at 9.30 and ends 21. May at 14.00


Please note, that the program might still change due to exceptional circumstances. Latest version and updates are presented here on the symposium web pages.